US HB8251 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on May 6 2024 - 25% progression
Action: 2024-05-06 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Status: Introduced on May 6 2024 - 25% progression
Action: 2024-05-06 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Summary
To direct the Secretary of Health and Human Services to streamline regulatory oversight of human cell and tissue products, and for other purposes.
Title
To direct the Secretary of Health and Human Services to streamline regulatory oversight of human cell and tissue products, and for other purposes.
Sponsors
Rep. Dan Crenshaw [R-TX] | Rep. Nanette Barragan [D-CA] |
History
Date | Chamber | Action |
---|---|---|
2024-05-06 | House | Referred to the House Committee on Energy and Commerce. |
2024-05-06 | House | Introduced in House |
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/8251/all-info |